The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / August / Vitrectomy Linked to Higher CME Risk
Retina Research & Innovations News

Vitrectomy Linked to Higher CME Risk

Large US database study suggests previous pars plana vitrectomy may substantially increase likelihood of pseudophakic cystoid macular edema

8/26/2026 3 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Report
  • Scorecard
  • Quiz
  • Poll
Objective:

To investigate the risk of developing cystoid macular edema (CME) after cataract surgery in patients with a history of pars plana vitrectomy (PPV).

Approach:
  • Study Design: A retrospective cohort study analyzing electronic health records from the TriNetX US Network, including 615,983 adults who underwent cataract surgery.
  • Patient Selection: Included 7,422 patients with prior PPV, excluding those with pre-existing CME or retinal conditions.
  • Data Analysis: Used propensity score matching to create 7,318 matched pairs for comparison.
Key Findings:
  • CME occurred in 4.59% of patients with prior PPV compared to 1.23% of controls, indicating a relative risk of 3.73 and an absolute difference of 3.36 percentage points.
  • Among patients with PPV for retinal detachment, CME rates were 5.65% versus 1.22% in controls.
  • For non-retinal-detachment indications, CME rates were 3.99% compared to 1.23% in controls.
  • The increased risk of CME persisted even after excluding intraoperative or postoperative complications.
Limitations:
  • Potential surveillance bias due to closer follow-up in previously vitrectomized patients.
  • Reliance on diagnostic and procedural codes without laterality data.
  • Possible residual confounding and lack of visual-acuity outcomes.
Sources:
  • JAMA Ophthalmology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: